Allison Hoffman of the Law School is quoted on how drug coverage will hinge largely on whether the company can find patients who say they have been unreasonably denied access to the treatment.
https://bit.ly/3rSb3z7 BloombergAllison Hoffman of the Law School is quoted on how drug coverage will hinge largely on whether the company can find patients who say they have been unreasonably denied access to the treatment.
https://bit.ly/3rSb3z7 Bloomberg